Talent Testing Service (TTS) has released the April 2024 update on positivity rates for various sexually transmitted diseases (STDs). The data reflects trends in positivity rates across different demographics, providing crucial insights for industry professionals and stakeholders.

Overall Trends: Chlamydia Urine Tests

• Total Rate: Increased from 0.5% to 1.0%.
• Male Rate: Rose slightly from 0.7% to 0.9%.
• Female Rate: Saw a significant increase from 0.2% to 1.2%.

These rates have shown a steady decline since peaking in November 2022, and although there has been a recent uptick, current levels remain within expectations, given the historical average of around 2.0%.

Gonorrhea Urine Tests

• Total Rate: Unchanged at 0.2%.
• Male Rate: Decreased from 0.4% to 0.2%.
• Female Rate: Dropped from 0.7% to 0.2%.

This marks the third consecutive month of downward trends, with rates consistently remaining within typical levels.

Syphilis Tests

• Total Rate: Unchanged at 0.4%.
• Male Rate: Decreased from 0.3% to 0.1%.
• Female Rate: Increased from 0.5% to 0.8%.

Despite the fluctuating trends, current positivity rates fall within the general range of 0.0% to 1.5%.

HIV Tests

• Total Rate: Unchanged at 4.7%.
• Male Rate: Increased from 3.7% to 4.9%.
• Female Rate: Decreased from 5.6% to 4.6%.

While the total rate remains stable, differing trends are observed between male and female groups.

Swab Tests (Chlamydia Rectal, Throat & Gonorrhea Rectal, Throat)

• Chlamydia Rectal:
  • Total Rate: Increased from 1.5% to 1.8%.
  • Male Rate: Decreased from 1.7% to 1.2%.
  • Female Rate: Increased from 1.4% to 2.4%.
• Chlamydia Throat:
  • Total Rate: Consistently below 1.0%.
  • Male Rate: Increased slightly to 0.1%.
• Gonorrhea Rectal:
  • Total Rate: Unchanged at 0.7%.
  • Male Rate: Increased from 0.6% to 1.0%.
  • Female Rate: Decreased from 0.7% to 0.4%.
• Gonorrhea Throat:
  • Total Rate: Unchanged at 1.2%.
  • Male Rate: Increased from 0.7% to 1.3%.
  • Female Rate: Decreased from 1.6% to 1.2%.

The trendlines demonstrate varied behavior across different swab tests, with the Gonorrhea Rectal lines showing greater volatility since April 2023.

Since 2005, TTS has set the standard for STD testing in the adult industry, offering a combination of safety, affordability, and convenience. With headquarters in Miami, Florida, and subsidiaries in major cities like Los Angeles, Tampa, Orlando, Las Vegas, Puerto Rico, and Budapest, the organization is dedicated to providing advanced molecular testing for the well-being of talents.

“We remain committed to ensuring the safety and health of talents in our industry,” said Avery Martin, spokesperson for TTS. “Our April 2024 update provides valuable insights into STD trends, helping creators and producers make informed decisions to protect their teams.”

To learn more about TTS’s services or to access historical STD trends, visit the official Talent Testing Service website.

Key April 2024 Trends at a Glance:

• Chlamydia Urine Total Rate: 1.0% (up from 0.5%).
• Gonorrhea Urine Female Rate: 0.2% (down from 0.7%).
• Syphilis Female Rate: 0.8% (up from 0.5%).
• HIV Total Rate: 4.7% (unchanged).

TTS continues to set the gold standard in the industry for molecular testing, ensuring the safety and well-being of talents across the globe.

You can follow Talent Testing Service on X at @TalentTesting.